TY - CHAP M1 - Book, Section TI - Primary Myelofibrosis A1 - Damon, Lloyd E. A1 - Andreadis, Charalambos Babis A2 - Papadakis, Maxine A. A2 - Rabow, Michael W. A2 - McQuaid, Kenneth R. A2 - Gandhi, Monica PY - 2025 T2 - Current Medical Diagnosis & Treatment 2025 AB - Key Clinical Updates in Primary MyelofibrosisThe newer JAK2 inhibitor pacritinib is an option for patients with a platelet count less than 50,000/mcL (50 × 109/L).RAS/CBL mutations predict resistance to ruxolitinib therapy.Tefferi A. Am J Hematol. [PMID: 36680511] SN - PB - McGraw-Hill Education CY - New York, NY Y2 - 2024/11/12 UR - accessmedicine.mhmedical.com/content.aspx?aid=1209225582 ER -